Скачать или смотреть Beyond Chemotherapy in ALL: Emerging Bispecific Antibodies, CAR T-cell Therapies, and Evolving Tr...

In this episode, Dr Ibrahim Aldoss and Dr Bijal Shah discuss how immunotherapy has transformed the treatment landscape of acute lymphoblastic leukemia (ALL), particularly in relapsed/refractory B-cell ALL, including:




• CD19-directed CAR T-cell therapies


• Next-generation CD19 bispecific antibodies


• The evolving role of allogeneic transplant




Presenters:



Ibrahim Aldoss, MD

Associate Professor

Division of Leukemia

Department of Hematology/HCT

City of Hope National Medical Center

Duarte, California



Bijal Shah, MD, MS

Senior Member, Department of Malignant Hematology

Moffitt Cancer Center

Tampa, Florida



Link to full program: 
https://bit.ly/4cRjiUi



Get access to all of our new podcasts by subscribing to the Decera Clinical Education [Oncology] Podcast on Apple Podcasts, YouTube Music, or Spotify.



Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com (https://pcm.adswizz.com) for information about our collection and use of personal data for advertising.